Direct thrombin inhibitors for non-ST–segment elevation acute coronary syndromes: what, when, and where?
- 31 October 2003
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 146 (4) , S23-S30
- https://doi.org/10.1016/j.ahj.2003.09.005
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Biologic rationale for the therapeutic role of specific antithrombinsCoronary Artery Disease, 1996
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Thrombosis in Unstable AnginaNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Angiographic demonstration of a common link between unstable angina pectoris and non-Q wave acute myocardial infarctionThe American Journal of Cardiology, 1988
- Coronary Arteriographic Findings Soon after Non-Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1986
- TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSISThe Lancet, 1978